Pharma Mar (XMAD:PHM) Price-to-Tangible-Book : 3.30 (As of May. 22, 2024)

View and export this data going back to 2000. Start your Free Trial

What is Pharma Mar Price-to-Tangible-Book?

As of today (2024-05-22), Pharma Mar's share price is €36.02. Pharma Mar's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was €10.91. Hence, Pharma Mar's Price to Tangible Book Ratio of today is 3.30.

The historical rank and industry rank for Pharma Mar's Price-to-Tangible-Book or its related term are showing as below:

XMAD:PHM' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.63 Med: 14.67 Max: 149.27
Current: 3.3

During the past 13 years, Pharma Mar's highest Price to Tangible Book Ratio was 149.27. The lowest was 2.63. And the median was 14.67.

XMAD:PHM's Price-to-Tangible-Book is ranked worse than
56.99% of 1223 companies
in the Biotechnology industry
Industry Median: 2.85 vs XMAD:PHM: 3.30

A closely related ratio is called PB Ratio. As of today, Pharma Mar's share price is €36.02. Pharma Mar's Book Value per Sharefor the quarter that ended in Mar. 2024 was €11.01. Hence, Pharma Mar's P/B Ratio of today is 3.27.

Pharma Mar Price-to-Tangible-Book Historical Data

The historical data trend for Pharma Mar's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Mar Price-to-Tangible-Book Chart

Pharma Mar Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

149.27

13.01

5.88

5.28

3.78

Pharma Mar Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Tangible-Book	Get a 7-Day Free Trial															3.70	2.63	2.80	3.78	2.64

Competitive Comparison of Pharma Mar's Price-to-Tangible-Book

For the Biotechnology subindustry, Pharma Mar's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharma Mar's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Mar's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Pharma Mar's Price-to-Tangible-Book falls into.

Pharma Mar Price-to-Tangible-Book Calculation

Pharma Mar's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2024 )
	=	36.02	/	10.906
	=	3.30

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Pharma Mar Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Pharma Mar's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Mar (XMAD:PHM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (XMAD:PHM) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

PHMMF:USA PHMe:UK 0RC6:UK

Address

Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770

Website

http://www.pharmamar.com

Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.